Multiple Myeloma
9 competing products in clinical development for Multiple Myeloma.
Pipeline by Phase
Phase 14
Phase 1/23
Phase 22
All Products (9)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Palonosetron | Eisai | Phase 2 | Completed | 35 |
| KW-2478 + Bortezomib | Kyowa Kirin | Phase 1/2 | Completed | 32 |
| KW-2478 | Kyowa Kirin | Phase 1 | Completed | 29 |
| PHE885 | Novartis | Phase 2 | Terminated | 27 |
| ASP7487, Velcade, Dexamethasone | Astellas Pharma | Phase 1/2 | Terminated | 24 |
| NEX-20A | Nanexa AB | Phase 1 | Completed | 23 |
| Denileukin Diftitox (Ontak) | Eisai | Phase 1 | Terminated | 21 |
| BIW-8962 | Kyowa Kirin | Phase 1 | Terminated | 21 |
| Temferon | Genenta Science | Phase 1/2 | Terminated | 14 |